JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
PUT
Five Below
FIVE
$13.2B
| $192K | ﹤0.01% |
+1,500
| New | +$188K |
|
4502
InMode
INMD
$875M
| $192K | ﹤0.01% |
+9,794
| New | +$184K |
|
|
JPUS
4503
JPMorgan Diversified Return US Equity ETF
JPUS
$467M
| $190K | ﹤0.01% |
2,389
-9,631
| -80% | -$744K |
|
4504
Tower Semiconductor
TSEM
$29.4B
| $190K | ﹤0.01% |
7,888
-221,379
| -97% | -$4.97M |
|
|
ZAGG
4505
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $190K | ﹤0.01% |
23,400
+13,700
| +141% | +$102K |
|
|
PGNX
4506
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $190K | ﹤0.01% |
37,417
+8,915
| +31% | +$47.2K |
|
|
VIOT
4507
Viomi Technology
VIOT
$48M
| $189K | ﹤0.01% |
+23,530
| New | +$203K |
|
|
FNCB
4508
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $188K | ﹤0.01% |
22,316
+16,707
| +298% | +$131K |
|
4509
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
| $187K | ﹤0.01% |
8,554
-2,574
| -23% | -$54.4K |
|
|
HES
4510
CALL
DELISTED
Hess
HES
| $187K | ﹤0.01% |
2,800
-24,200
| -90% | -$1.58M |
|
4511
PUT
Steel Dynamics
STLD
$37.7B
| $187K | ﹤0.01% |
+5,500
| New | +$176K |
|
4512
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$291M
| $186K | ﹤0.01% |
5,245
-132
| -2% | -$4.59K |
|
4513
Gold Fields
GFI
$36.4B
| $185K | ﹤0.01% |
28,045
-1,261,491
| -98% | -$7.15M |
|
4514
iShares Global Healthcare ETF
IXJ
$4.23B
| $184K | ﹤0.01% |
2,670
-6,491
| -71% | -$421K |
|
4515
TFS Financial
TFSL
$4.89B
| $184K | ﹤0.01% |
9,327
+227
| +2% | +$4.38K |
|
4516
Union Bankshares
UNB
$120M
| $184K | ﹤0.01% |
5,082
+3,806
| +298% | +$130K |
|
|
ESTE
4517
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $184K | ﹤0.01% |
29,095
-124,852
| -81% | -$587K |
|
4518
Arcos Dorados Holdings
ARCO
$1.66B
| $183K | ﹤0.01% |
23,229
-593,414
| -96% | -$4.28M |
|
4519
Mistras Group
MG
$556M
| $183K | ﹤0.01% |
12,855
-18,261
| -59% | -$258K |
|
4520
TETRA Technologies
TTI
$1.29B
| $183K | ﹤0.01% |
93,313
-75
| -0.1% | -$121 |
|
4521
Anterix
ATEX
$1.73B
| $182K | ﹤0.01% |
4,216
-16,470
| -80% | -$671K |
|
4522
Compugen
CGEN
$236M
| $182K | ﹤0.01% |
+30,572
| New | +$157K |
|
|
OYST
4523
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $182K | ﹤0.01% |
+7,430
| New | +$130K |
|
|
MFNC
4524
DELISTED
Mackinac Financial Corporation
MFNC
| $182K | ﹤0.01% |
10,433
+7,368
| +240% | +$117K |
|
4525
Lee Enterprises
LEE
$182M
| $181K | ﹤0.01% |
12,773
-3,997
| -24% | -$71.3K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.